Coleus Forskohlii Extract, derived from the plant Coleus forskohlii of the Lamiaceae family, has Forskolin as its main active component—a labdane-type diterpenoid compound with unique physiological activities. Its core mechanism of action is to specifically activate adenylate cyclase (AC) in eukaryotic cells, thereby increasing intracellular cyclic adenosine monophosphate (cAMP) levels. By regulating signaling pathways such as protein kinase A (PKA), it participates in various physiological processes including cell differentiation, proliferation, and metabolic regulation. This extract has traditionally been used in regions like India to alleviate respiratory diseases and regulate cardiovascular function, and modern research has further explored its application value in multiple fields.
Common Application Fields are broad and diverse. In the field of scientific research, Forskolin is an important tool for stem cell and organoid research. It can not only upregulate the expression of pluripotency genes such as Oct4 and Sox2 to maintain the self-renewal of embryonic stem cells, but also induce their differentiation into neural precursor cells, and promote the structural maturation and functional improvement of intestinal and liver organoids. In pharmaceutical research, it has shown effects of inhibiting proliferation and inducing apoptosis of tumor cells such as myeloma and lymphoma. Meanwhile, in terms of glucose metabolism regulation, it can improve blood glucose levels and insulin sensitivity in insulin-resistant mice, providing new ideas for metabolic disease research. In the dietary supplement field, it is used as a weight management ingredient, and related products are often labeled with claims such as "dairy-free, gluten-free, vegetarian" to meet modern healthy consumption needs. In addition, its traditional effects of cardiotonic, hypotensive, and antispasmodic also provide references for drug development.
Regulatory Status in Various Countries shows a differentiated regulatory situation. The United States classifies it as a dietary supplement raw material, which must comply with the standards of the Dietary Supplement Health and Education Act (DSHEA), and manufacturers need to ensure product compliance. The EU market requires products to comply with EU food supplement regulations and follow the relevant evaluation guidelines of the European Food Safety Authority (EFSA). Australia has included it in the list of compliant raw materials through the Therapeutic Goods Administration (TGA), allowing its use in products that meet standards. As one of the major producing countries, India's leading enterprises have obtained multiple international certifications such as FDA compliance, USDA organic certification, and FSSC 22000 for their products, meeting the market access requirements of many regions around the world. Currently, China regards it as an ordinary plant extract, which must comply with the general safety standards for food raw materials. There is no separate approval directory specifically for its use as a health food raw material, and related products need to be produced and registered in accordance with the Food Safety Law and the regulatory framework for plant extract raw materials.
Product
